For Oman to successfully attract international medical tourists, its hospitals must guarantee uninterrupted access to cutting-edge medical devices, advanced therapeutics, and high quality pharmaceuticals. This requires a shift from import dependency to In-Country Value (ICV). With the Omani pharmaceutical market projected to exceed $1.24 billion by 2031, this theme positions local manufacturing not just as an economic diversifier, but as the critical supply chain backbone of health tourism.